Votrient Related Clinical Trials
PAZOFOS: Phase Ib and Phase II Trial of Pazopanib +/- Fosbretabulin in Advanced Recurrent Ovarian Cancer [Recruiting]
A Phase 1B Dose-escalation and Phase 2a Study of TRC105 in Combination With Pazopanib in Patients With Advanced Soft Tissue Sarcoma [Recruiting]
Patient Preference Study of Pazopanib Versus Sunitinib in Advanced or Metastatic Kidney Cancer [Active, not recruiting]
Phase II Study of the Optimal Scheme of Administration of Pazopanib in Thyroid Carcinoma [Recruiting]
Pazopanib or Pemetrexed and Crizotinib in Advanced Cancer [Recruiting]
VEG113971: An Open-Label Study of the Effects of Ketoconazole or Esomeprazole on Pazopanib PK [Completed]
Pilot Clinical Trial of Pazopanib in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) or at Initial Diagnosis When no Intensive Treatment is Possible [Recruiting]
A Combination of Pazopanib and Carboplatin in Advanced Solid Malignancies [Terminated]
Pazopanib Tolerability When Given With Food [Recruiting]
Pazopanib Hydrochloride in Treating Patients With Advanced or Refractory Solid Tumors [Recruiting]
Pazopanib and Everolimus in PI3KCA Mutation Positive/PTEN Loss Patients [Active, not recruiting]
Part A: Radiolabel Study With GW786034 Part B: Single Dose of GW786034 [Completed]
Pazopanib vs. Pazopanib Plus Gemcitabine in Patients With Relapsed or Metastatic Uterine Leiomyosarcomas or Uterine Carcinosarcomas: a Multi-center, Randomized Phase-II Clinical Trial of the NOGGO and AGO - PazoDoble - [Recruiting]
Temsirolimus and Pazopanib in Patients With Advanced Solid Tumors [Completed]
Pazopanib Hydrochloride Followed by Chemotherapy and Surgery in Treating Patients With Soft Tissue Sarcoma [Recruiting]
First Line Pazopanib in Poor Risk Patients With Metastatic Renal Cell Carcinoma [Recruiting]
Pazopanib (VOTRIENT) Plus Paclitaxel (TAXOL), Pazopanib Plus Paclitaxel (TAXOL) Plus Carboplatin (PARAPLATIN), and Pazopanib Plus Paclitaxel (TAXOL) Plus Lapatinib (TYKERB) [Completed]
Treatment of Corneal Neovascularization With Topical Pazopanib [Completed]
Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment [Completed]
Efficacy of Pazopanib in Gastrointestinal Stromal Tumors (GIST) [Active, not recruiting]
Pazopanib, Docetaxel, Prednisone Prostate [Active, not recruiting]
Everolimus Post Pazopanib Treatment in Metastatic or Advanced Renal Cell Carcinoma [Recruiting]
Pazopanib in Advanced and Cisplatin-resistant Germ Cell Tumors [Not yet recruiting]
Study of Pazopanib and Doxil in Patients With Advanced Relapsed Platinum-Sensitive or Platinum-Resistant Ovarian, Fallopian Tube or Primary Peritoneal Adenocarcinoma [Terminated]
Study of Preoperative Therapy With Pazopanib (Votrient®) to Treat High-risk Soft Tissue Sarcoma [Recruiting]
Nivolumab (BMS-936558; MDX-1106) in Combination With Sunitinib, Pazopanib, or Ipilimumab in Subjects With Metastatic Renal Cell Carcinoma (RCC) (CheckMate 016) [Active, not recruiting]
Study of Pazopanib and Paclitaxel in Advanced Non-small Cell Lung Cancer [Completed]
Pazopanib As Pre-Surgical Therapy In Treatment-Naive Subjects With Non-Small Cell Lung Cancer [Completed]
A Phase II, Open-Label Study Evaluating the Effect Of GW786034 In Subjects With Ovarian Cancer [Completed]
A Pilot Study of SBRT With Adjuvant Pazopanib for Renal Cell Cancer [Not yet recruiting]
Randomized, Double-Blind Trial of Erlotinib/Pazopanib or Erlotinib/Placebo in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer [Completed]
Phase I Dose Escalation Study of Topotecan and Pazopanib in Children With Recurrent/Refractory Solid and CNS Tumours [Recruiting]
Pazopanib Paediatric Phase II Trial Children's Oncology Group (COG) in Solid Tumors [Recruiting]
PAZOPANIB Efficacy and Tolerance in Desmoids Tumors [Recruiting]
Pazopanib in Second-line Therapy in Renal Cell Carcinoma [Active, not recruiting]
Pazopanib Maintenance Phase II [Recruiting]
Pazopanib in Molecularly Selected Patients With Advanced NSCLC [Recruiting]
Pazopanib and Weekly Topotecan in Patients Recurrent Ovarian Cancer (TOPAZ) [Recruiting]
Pazopanib, Lapatinib or Trastuzumab in Subjects With Solid Tumors [Completed]
Phase I Clinical and Pharmacokinetic Study of Pazopanib in a Population of Frail Elderly Patients According SIOG Criteria [Recruiting]
Pazopanib in Treating Patients With Advanced Neuroendocrine Cancer [Active, not recruiting]
A Phase I, Open-label, Study of Pazopanib in Combination With Epirubicin or Doxorubicin for Advanced Solid Tumors [Completed]
Study To Assess Long Term Safety Of Pazopanib [Active, not recruiting]
Gemcitabine Hydrochloride With or Without Pazopanib Hydrochloride in Treating Patients With Refractory Soft Tissue Sarcoma [Recruiting]
Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Measuring Effects of Pazopanib Hydrochloride in Patients With Metastatic Kidney Cancer [Active, not recruiting]
Pazopanib in Treating Patients With Newly Diagnosed or Locally and/or Regionally Recurrent Breast Cancer That Can Be Removed By Surgery [Terminated]
A Safety Study to Evaluate Pazopanib Eye Drops in Healthy Volunteers [Completed]
Pazopanib In Combination With Lapatinib In Adult Patients With Relapsed Malignant Glioma [Completed]
Pazopanib Hydrochloride in Treating Patients With Advanced or Progressive Malignant Pheochromocytoma or Paraganglioma [Terminated]
VEG111485: A QTc Study of Pazopanib [Completed]
Pazopanib in Combination With Capecitabine in Patients With Metastatic Breast Cancer [Completed]
A Phase I Study of Pazopanib in Adult Patients With Liver Cancer [Completed]
Pazopanib Hydrochloride and Bevacizumab in Treating Patients With Previously Untreated Metastatic Kidney Cancer [Recruiting]
Phase I Study of Pazopanib and Vorinostat [Recruiting]
Neoadjuvant Pazopanib in Renal Cell Carcinoma [Recruiting]
To Evaluate the Pharmacodynamics, Safety, and Pharmacokinetics of Pazopanib Drops in Adult Subjects With Neovascular AMD [Completed]
Pazopanib Hydrochloride With or Without Bicalutamide in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy [Active, not recruiting]
Pazopanib Maintenance for SCLC [Recruiting]
HYPAZ: Hypertension Induced by Pazopanib [Terminated]
Study With Pazopanib and Weekly Paclitaxel in Penile Carcinoma (PAZOPEN-SOGUG) [Not yet recruiting]
Phase I/II Study of Pazopanib+ Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme [Recruiting]
Rotating Pazopanib and Everolimus to Avoid Resistance [Completed]
Pazopanib and Vinflunine in Urothelial Cancer of the Bladder [Completed]
Pazopanib Versus Temsirolimus in Poor-Risk Clear-Cell Renal Cell Carcinoma (RCC) [Recruiting]
Treatment With Pazopanib for Neoadjuvant Breast Cancer [Completed]
Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Inflammatory Breast Cancer [Completed]
Study of Pazopanib and Ixabepilone in Patients With Solid Tumors [Completed]
Pazopanib Hydrochloride in Treating Patients With Advanced Angiosarcoma [Recruiting]
Pazopanib Hydrochloride Before Surgery in Treating Patients With Kidney Cancer [Suspended]
Pazopanib in Previously Treated Patients With Metastatic Renal Cell Carcinoma [Completed]
A Study To Test The Effect Of GW786034 (Pazopanib) On P450 Enzymes [Completed]
Study of Pazopanib in the Treatment of Osteosarcoma Metastatic to the Lung [Recruiting]
Pazopanib Hydrochloride in Treating Patients With Recurrent or Persistent Uterine Cancer [Active, not recruiting]
Pazopanib Plus Cetuximab for Incurable Head and Neck Squamous Cell Carcinoma (HNSCC) [Recruiting]
Pazopanib and Paclitaxel as First-Line Treatment for Subjects With Unresectable Stage III and Stage IV Melanoma [Recruiting]
Phase III Sequential Open-label Study to Evaluate the Efficacy and Safety of Sorafenib Followed by Pazopanib Versus Pazopanib Followed by Sorafenib in the Treatment of Advanced / Metastatic Renal Cell Carcinoma (SWITCH-II) [Recruiting]
Phase II Study of Pazopanib and Topotecan in Cervical Cancer [Not yet recruiting]
Paclitaxel/Pazopanib for Platinum Resistant/Refractory Ovarian Cancer [Not yet recruiting]
Pazopanib Hydrochloride in Treating Patients With Metastatic Melanoma That Cannot be Removed by Surgery [Active, not recruiting]
Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Chondrosarcoma [Recruiting]
A Phase I, Open-label, Study of Pazopanib in Combination With Gemcitabine and Gemcitabine Plus Cisplatin for Advanced Solid Tumors [Completed]
Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer [Recruiting]
A Study of Pazopanib With CAPEOX in AGC Patients [Recruiting]
Study Of The Repeat Dosing Of Ketoconazole On The Pharmacokinetics Of A Single Dose Of Pazopanib (GW786034) Eye Drops [Completed]
Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Liposarcoma [Active, not recruiting]
A Phase I Study Of Pazopanib With Either Erlotinib Or Pemetrexed In Patients With Advanced Solid Tumors [Completed]
Hepatic Monitoring for Pazopanib [Completed]
Pazopanib in Treating Patients With Recurrent Glioblastoma [Completed]
Trial of Pazopanib in Patients With Solitary Fibrous Tumor and Extraskeletal Myxoid Chondrosarcoma [Recruiting]
Pazopanib in Treating Patients With Recurrent or Metastatic Breast Cancer [Completed]
|